SOURCE: IDenta Corp.

March 31, 2011 10:00 ET

International Drug & Explosives Detection Company IDenta Corp. Releases Updated 15(c)-211

JERUSALEM--(Marketwire - March 31, 2011) - IDenta Corp. (PINKSHEETS: IDTA) CEO Yaacov Shoham today announced that the company has released an updated form 15(c)-211.

Mr. Shoham made the following statement, "We have made available this updated 15(c)-211 form as a first step in releasing information about the large activity of the company. Business at IDenta has been progressing at a very accelerated rate and we will be releasing additional information about the company in the coming weeks. We are also presently working to make IDenta a listed company.

The 15(c)-211 report can be viewed with the following link now and will be posted to pink sheets (otcmarkets.com) in the near future.

https://www.yousendit.com/download/UFh1NU1LbEo4Q1N4dnc9PQ

"IDenta's entire product line may be found at www.Identa-corp.com and www.identa.biz.

ABOUT IDENTA

Since 2003, IDenta Corporation has been recognized as a worldwide leader in the development of proprietary on-site drug, drug precursor and explosive detection kits. IDenta develops, manufactures and distributes products for both the professional and civil markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world.

DISCLAIMER

Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.

For Investor Relations, lobbying interests or information concerning IDenta's products internationally or the development of new chemical detectors, contact: Yaacov Shoham, IDenta Corp., CEO, Tel: +972-52-6554487, fpi@drugsdetector.com, www.identa.biz. www.identa-corp.com.

Contact Information